These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5972035)

  • 21. Pharmacological properties of tofenacine hydrochloride: N-methyl-2-[(o-methyl-a-phenylbenzyl)oxy]ethylamine hydrochloride.
    Funcke AB; Mulder D; van Beek MC; Timmerman H; van Hell G; Lavy UI; Nauta WT
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):28-51. PubMed ID: 4390937
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in electrocardiograms caused by amiodarone].
    Friart J; Rasson G
    Arzneimittelforschung; 1971 Oct; 21(10):1535-41. PubMed ID: 5171881
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects due to treatment of hypertension with prazosin.
    Bendall MJ; Baloch KH; Wilson PR
    Br Med J; 1975 Jun; 2(5973):727-8. PubMed ID: 1139197
    [No Abstract]   [Full Text] [Related]  

  • 24. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypotension induced by molsidomine or trinitroglycerin].
    Dassier P; Blanloeil Y; Pinaud M; Bodin D; Vandeville B
    Cah Anesthesiol; 1985; 33(4):309-13. PubMed ID: 3931864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 27. Demonstration of the antihypertensive activity of phenyl-2-aminoethyl selenide.
    Pollock SH; Herman HH; Fowler LC; Edwards AS; Evans CO; May SW
    J Pharmacol Exp Ther; 1988 Jul; 246(1):227-34. PubMed ID: 3392654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and central nervous system depressant activity of new piperazine derivatives and related compounds. II.
    Vadodaria DJ; Deliwala CV; Mandrekar SS; Sheth UK
    J Med Chem; 1969 Sep; 12(5):860-5. PubMed ID: 5812200
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychomotor performance and antihypertensive treatment.
    Kalra L; Swift CG; Jackson SH
    Br J Clin Pharmacol; 1994 Feb; 37(2):165-72. PubMed ID: 8186062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the pharmacology of some condensed indole systems].
    Batulin IuM; Klygul' TA; Kovaleva AE; Fedorova IB; Aksanova LA
    Farmakol Toksikol; 1966; 29(5):590-4. PubMed ID: 5995070
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of new tropine ethers with central activity.
    György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
    Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
    [No Abstract]   [Full Text] [Related]  

  • 32. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1995 Feb; 114(3):584-91. PubMed ID: 7735684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trial of an antihypertensive agent: antipressin].
    Warembourg H; Théry C
    Lille Med; 1967 Feb; 12(2):Suppl:143-6. PubMed ID: 5623385
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chemical and pharmacological study of new derivatives of noradrenaline].
    Régnier G; Canevari R; Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370
    [No Abstract]   [Full Text] [Related]  

  • 35. Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events.
    Wang K; Wan M; Wang RS; Weng Z
    J Med Internet Res; 2016 Apr; 18(4):e76. PubMed ID: 27036325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the noradrenaline alpha-receptor. II. Analysis of the "spare-receptor" hypothesis and estimation of the concentration of alpha-receptors in rabbit aorta.
    May M; Moran JF; Kimelberg H; Triggle DJ
    Mol Pharmacol; 1967 Jan; 3(1):28-36. PubMed ID: 6030891
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antihypertensive agents--principles of combination drug therapy].
    Ruskoaho H
    Duodecim; 2000; 116(24):2826-30. PubMed ID: 12077888
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
    Ciplea A; Bubuianu G
    Rev Roum Physiol; 1969; 6(4):267-74. PubMed ID: 4926779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.